Galectin Therapeutics Inc. logo GALT - Galectin Therapeutics Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 9
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $11.00 DETAILS
HIGH: $11.00
LOW: $11.00
MEDIAN: $11.00
CONSENSUS: $11.00
UPSIDE: 120.44%
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0 0 0 0 0 0 0.0 0.1 0.1 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0 0 0 0 0 0 (5.3) (6.5) (7.0) 0 0 0 0 0 0
Operating Expenses
R&D Expenses 14.3 36.6 32.1 31.7 23.8 18.0 7.5 6.5 11.7 15.3 13.1 8.4 5.7 4.5 3.6 1.1 1.1 1.8 2.1 3.0 3.0 3.0 2.0 1.5 0.9 0.1
SG&A Expenses 5.8 5.9 5.9 6.6 6.4 5.5 6.0 7.1 4.5 6.2 7.0 7.0 6.4 5.4 6.9 3.8 5.0 3.6 4.4 4.0 3.6 4.3 3.0 1.8 1.3 0.1
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 20.1 42.4 38.1 38.4 30.2 23.4 13.4 13.6 16.2 21.5 20.1 15.4 12.1 9.9 10.4 4.9 6.1 5.3 6.5 7.0 6.7 7.3 4.9 3.3 2.2 0.2
Operating Income
Operating Income (20.1) (42.4) (38.1) (38.4) (30.2) (23.4) (13.4) (13.6) (16.2) (21.5) (20.1) (15.4) (12.1) (9.9) (10.4) (4.9) (6.1) (5.3) (6.5) (7.0) (6.7) (7.3) (4.9) (3.3) (2.2) (0.2)
Interest Expense 7.3 5.5 2.8 1.0 0.5 0.1 0.1 0.3 0.0 0 0 0 0 0 0 0 0 0 0.3 1.9 0 0 0.0 0.4 0 0
Interest Income 0.1 0.3 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0
Profitability
EBITDA (23.5) (41.5) (38.2) (37.7) (30.0) (23.3) (13.2) (13.6) (16.2) (21.5) (20.0) (15.8) (12.1) (9.7) (10.9) (5.6) (7.4) (3.1) (9.0) (1.3) (6.8) (7.1) (4.8) (3.1) (2.0) (0.2)
EBIT (23.5) (41.5) (38.3) (37.7) (30.0) (23.4) (13.2) (13.6) (16.2) (21.5) (20.0) (15.8) (12.1) (9.7) (10.9) (5.6) (7.5) (3.2) (9.1) (1.3) (6.9) (7.2) (4.9) (3.3) (2.2) (0.2)
Income Before Tax (30.8) (47.0) (41.1) (38.8) (30.5) (23.5) (13.3) (13.9) (16.2) (21.4) (20.0) (15.8) (12.1) (9.7) (10.9) (5.6) (7.5) (3.2) (9.4) (3.2) (6.5) (7.2) (4.9) (3.7) (2.2) (0.2)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.8 0
Net Income (30.8) (47.0) (41.1) (38.8) (30.5) (23.5) (13.3) (13.9) (16.2) (21.4) (20.0) (15.8) (12.1) (9.7) (10.9) (5.6) (7.5) (3.2) (9.4) (3.2) (6.5) (7.2) (4.9) (3.7) (4.0) (0.2)
Per Share Data
EPS (Basic) -0.48 -0.76 -0.74 -0.65 -0.52 -0.41 -0.39 -0.35 -0.46 -0.73 -0.83 -0.72 -0.72 -0.64 -0.91 -0.60 -0.93 -0.40 -1.45 -0.67 -1.44 -1.67 -1.37 -1.35 -1.75 -0.09
EPS (Diluted) -0.48 -0.76 -0.74 -0.65 -0.52 -0.41 -0.39 -0.35 -0.46 -0.73 -0.83 -0.72 -0.72 -0.64 -0.91 -0.60 -0.93 -0.40 -1.45 -0.67 -1.44 -1.67 -1.37 -1.35 -1.75 -0.09
Shares Outstanding 63.9 62.3 60.2 59.4 58.5 57.0 52.2 39.4 35.5 29.2 24.1 21.8 16.9 15.1 12.0 9.4 8.0 7.8 6.5 4.7 4.6 4.3 3.6 2.7 2.3 2.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Current Assets
Cash & Cash Equivalents 17.7 15.1 25.7 18.6 39.6 27.1 47.5 8.3 3.1 15.4 25.8 29.1 10.5 9.4 6.4 5.9 0.3 0.3 1.3 0.8 4.5 10.7 7.6 1.9 1.5 0.2
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 1.7 2.1 2.0 2.0 2.2 2.3 0.7 0.6 0.0 0.0 0.0 0.0 0 0 0.1 0 0 0 0 0 0 0 0 0 0.1 0
Total Current Assets 19.4 17.3 27.7 20.6 41.8 29.5 48.2 8.8 3.8 15.8 26.4 29.7 10.7 9.5 6.5 6.2 0.3 0.4 1.4 5.9 4.7 10.8 7.7 2.0 1.6 0.2
Non-Current Assets
Property, Plant & Equipment 0 0 0.1 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.2 0.2 0.1 0.1 0.1 0.0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0.1 0.2 0.4 0.7 0.0 0.1 0.3 0.2 0.3 0 0 0 0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0 0.0 0.0 0.0 0.0 0.0
Total Non-Current Assets 0.1 0.2 0.5 0.7 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.0
Total Assets 19.5 17.5 28.2 21.3 41.8 29.6 48.5 9.0 4.2 15.8 26.4 29.7 10.7 9.6 6.6 6.3 0.4 0.7 1.8 6.4 5.0 11.1 8.0 2.3 1.8 0.2
Current Liabilities
Account Payables 3.2 5.7 6.4 3.9 1.8 1.3 1.7 0.3 0.6 0.9 0.4 0.9 0.8 0.4 0.4 0.1 0.2 0.4 0.6 0.3 0.3 0.2 0.2 0.3 0.2 0.1
Short-Term Debt 0 21.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0.0 0.2 0.1
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0.2 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 1.1 1.9 8.1 8.1 6.5 3.3 0.1 0.5 1.6 2.2 0.3 0.2 1.2 1.2 1.2 0.9 0 0 1.9 5.1 0 0 0 0.2 0 0.0
Total Current Liabilities 8.0 35.4 15.7 13.0 9.0 5.4 2.8 2.1 3.0 3.8 1.4 1.7 2.5 1.6 2.2 1.8 1.1 1.1 2.6 6.0 1.4 1.0 0.4 0.7 0.6 0.2
Non-Current Liabilities
Long-Term Debt 133.7 85.1 71.7 39.8 29.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 4.0 0.0 1.0 0.6 1.1 0.0 0.1 0 0 0 0 0 0 0.0 0 6.2 3.9 0.1 2.1 0.4 0 0 0 0 0 0
Total Non-Current Liabilities 137.7 85.2 72.8 40.5 30.2 0.0 0.1 0 0 0 0 0 0 0.0 0 6.2 3.9 0.1 2.1 0.4 0 0 0 0 0 0
Total Liabilities 145.7 120.6 88.4 53.5 39.2 5.4 2.9 2.1 3.0 3.8 1.4 1.7 2.5 1.6 2.2 8.0 4.9 1.2 4.7 6.4 1.4 1.0 0.4 0.7 0.6 0.2
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0.0
Retained Earnings (432.5) (401.6) (354.4) (309.6) (270.7) (240.0) (216.4) (196.2) (181.2) (163.7) (140.0) (118.9) (102.0) (80.0) (69.1) (56.4) (47.7) (38.5) (35.2) (25.7) (26.4) (19.9) (12.7) (7.8) (4.2) (0.2)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.3) (0.3) (0.3) 0 0 (0.3) (0.0) (0.1) (0.2) (0.1) 0
Total Stockholders' Equity (126.2) (103.1) (60.2) (32.2) 2.6 24.2 45.6 6.9 1.2 12.0 25.0 28.0 8.2 7.9 4.4 (1.7) (4.5) (0.5) (2.9) (0.0) 3.6 10.1 7.6 1.6 1.2 0.1
Total Liabilities & Equity 19.5 17.5 28.2 21.3 41.8 29.6 48.5 9.0 4.2 15.8 26.4 29.7 10.7 9.6 6.6 6.3 0.4 0.7 1.8 6.4 5.0 11.1 8.0 2.3 1.8 0.2
Debt Metrics
Total Debt 133.8 106.2 71.8 39.9 29.1 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0.2 0 5.1 0 0 0 0.0 0.2 0.1
Net Debt 116.0 91.1 46.1 21.3 (10.6) (27.1) (47.4) (8.3) (3.1) (15.4) (25.8) (29.1) (10.5) (9.4) (6.4) (5.9) (0.3) (0.1) (1.3) (0.8) (4.5) (10.7) (7.6) (1.9) (1.3) (0.1)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Operating Activities
Net Income (30.8) (47.0) (41.1) (38.8) (30.5) (23.5) (13.3) (13.9) (16.2) (21.4) (20.0) (15.8) (12.1) (9.9) (10.9) (5.6) (7.5) (3.2) (9.4) (3.2) (6.5) (7.2) (4.9) (3.7) (4.0) (0.2)
Depreciation & Amortization 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0
Stock-Based Compensation 1.7 2.4 2.3 2.9 2.1 1.8 1.7 4.4 1.1 2.5 3.4 4.1 3.8 0.0 3.2 1.9 1.6 0.7 0 0 0 0 0 0.1 0 0
Change in Working Capital 0.6 2.3 4.7 5.0 3.8 0.9 0.6 (1.1) (0.8) 2.5 (0.4) (1.1) 0.8 (0.6) 1.5 (0.7) 0.4 (0.1) 0.2 (0.4) 0.3 0.6 0 0.1 0.2 0.1
Other Non-Cash Items 4.6 0.5 1.1 (0.1) 0.4 0.1 0.1 0.3 0.0 0 0 0.4 0 3.0 0.5 1.3 1.5 (2.1) 4.3 (2.8) 0.1 0.2 1.3 0.2 1.9 0.0
Operating Cash Flow (23.9) (41.8) (33.0) (31.1) (24.3) (20.6) (10.8) (10.2) (15.9) (16.4) (17.0) (12.4) (7.5) (7.5) (5.7) (3.1) (3.9) (4.7) (5.5) (6.8) (6.1) (6.3) (4.2) (3.0) (1.8) (0.1)
Investing Activities
Capital Expenditure 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0 0 (0.0) (0.0) (0.1) (0.0) (0.0) (0.0) (0.1) (0.2) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 (0.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 (0.4) 0 0 0 0 0 0 0 (5) 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 (0.4) 0.4 0.1 0.1 (0.0) 0 0 0.0 (0.0) (0.1) (0.1) (0.0) (0.1) (0.0) (0.0) 0
Investing Cash Flow 0 0 0 0 0 0 0 0 0 0 0 (0.4) 0.1 0.1 (0.0) 0 0 0.0 4.9 (5.2) (0.1) (0.1) (0.1) (0.1) (0.2) (0.0)
Financing Activities
Net Debt Issuance 21 30 30 10 30 0 0 0 0 0 0 0 0 0 0 0 0 0.2 (0.6) 8.3 0 0 0 (0.1) 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (1.3) 0 0 0 0 0 0 0 0 0.0
Dividends Paid 0 (0.1) 0 0 (0.2) (0.1) (0.4) (0.9) (1.2) (0.7) (0.9) (0.9) 0 0 (1.5) (2.1) (0.2) 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0.1 10.0 0 0.2 0.1 0 0.9 1.2 0.7 0.9 3.1 4.8 0 7.6 7.3 0.0 0 1.6 0 0 0 0.0 0 1.0 0.3
Financing Cash Flow 26.5 31.2 40.0 10 36.8 0.3 50.1 15.4 3.6 5.9 13.7 31.5 8.6 10.4 6.2 8.7 3.8 3.7 1.1 8.3 0 9.5 9.9 3.6 3.3 0.3
Cash Position
Net Change in Cash 2.6 (10.5) 7.1 (21.1) 12.5 (20.3) 39.2 5.2 (12.3) (10.5) (3.3) 18.6 1.1 3.0 0.5 5.6 (0.1) (1.0) 0.5 (3.7) (6.2) 3.1 5.7 0.4 1.3 0.2
Cash at Beginning 15.1 25.7 18.6 39.6 27.1 47.5 8.3 3.1 15.4 25.8 29.1 10.5 9.4 6.4 5.9 0.3 0.3 1.3 0.8 4.5 10.7 7.6 1.9 1.5 0.2 0
Cash at End 17.7 15.1 25.7 18.6 39.6 27.1 47.5 8.3 3.1 15.4 25.8 29.1 10.5 9.4 6.4 5.9 0.3 0.3 1.3 0.8 4.5 10.7 7.6 1.9 1.5 0.2
Free Cash Flow (23.9) (41.8) (33.0) (31.1) (24.3) (20.6) (10.8) (10.2) (15.9) (16.4) (17.0) (12.4) (7.5) (7.5) (5.7) (3.1) (3.9) (4.7) (5.5) (6.9) (6.1) (6.4) (4.2) (3.1) (2.0) (0.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0 0 0 0 0 0 (5.3) (6.5) (7.0) 0 0 0 0 0 0
Operating Income (20.1) (42.4) (38.1) (38.4) (30.2) (23.4) (13.4) (13.6) (16.2) (21.5) (20.1) (15.4) (12.1) (9.9) (10.4) (4.9) (6.1) (5.3) (6.5) (7.0) (6.7) (7.3) (4.9) (3.3) (2.2) (0.2)
Net Income (30.8) (47.0) (41.1) (38.8) (30.5) (23.5) (13.3) (13.9) (16.2) (21.4) (20.0) (15.8) (12.1) (9.7) (10.9) (5.6) (7.5) (3.2) (9.4) (3.2) (6.5) (7.2) (4.9) (3.7) (4.0) (0.2)
EPS (Diluted) -0.48 -0.76 -0.74 -0.65 -0.52 -0.41 -0.39 -0.35 -0.46 -0.73 -0.83 -0.72 -0.72 -0.64 -0.91 -0.60 -0.93 -0.40 -1.45 -0.67 -1.44 -1.67 -1.37 -1.35 -1.75 -0.09
Balance Sheet
Cash & Equivalents 17.7 15.1 25.7 18.6 39.6 27.1 47.5 8.3 3.1 15.4 25.8 29.1 10.5 9.4 6.4 5.9 0.3 0.3 1.3 0.8 4.5 10.7 7.6 1.9 1.5 0.2
Total Assets 19.5 17.5 28.2 21.3 41.8 29.6 48.5 9.0 4.2 15.8 26.4 29.7 10.7 9.6 6.6 6.3 0.4 0.7 1.8 6.4 5.0 11.1 8.0 2.3 1.8 0.2
Total Debt 133.8 106.2 71.8 39.9 29.1 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0.2 0 5.1 0 0 0 0.0 0.2 0.1
Stockholders' Equity (126.2) (103.1) (60.2) (32.2) 2.6 24.2 45.6 6.9 1.2 12.0 25.0 28.0 8.2 7.9 4.4 (1.7) (4.5) (0.5) (2.9) (0.0) 3.6 10.1 7.6 1.6 1.2 0.1
Cash Flow
Operating Cash Flow (23.9) (41.8) (33.0) (31.1) (24.3) (20.6) (10.8) (10.2) (15.9) (16.4) (17.0) (12.4) (7.5) (7.5) (5.7) (3.1) (3.9) (4.7) (5.5) (6.8) (6.1) (6.3) (4.2) (3.0) (1.8) (0.1)
Capital Expenditure 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0 0 (0.0) (0.0) (0.1) (0.0) (0.0) (0.0) (0.1) (0.2) (0.0)
Free Cash Flow (23.9) (41.8) (33.0) (31.1) (24.3) (20.6) (10.8) (10.2) (15.9) (16.4) (17.0) (12.4) (7.5) (7.5) (5.7) (3.1) (3.9) (4.7) (5.5) (6.9) (6.1) (6.4) (4.2) (3.1) (2.0) (0.1)